治疗与帕金森病之间的关联:全国性,基于人口的研究
Kao-Sung Tsai1,2,3, Ming-Kuei Lu1,2, Chao-Hong Liu4,5
1School of Chinese Medicine, Graduate Institute of Integrated Medicine, College of Chinese Medicine, Ph.D. Program for Translational Medicine, College of Medicine, China Medical University, Taichung 404, Taiwan.
Pharmaceuticals (Basel, Switzerland)
|October 26, 2024
概括
患者面临着更高的帕金森病 (PD) 风险. 然而,林丹治疗可能会令人惊地降低PD风险,这表明潜在的神经保护作用.
科学领域:
- 神经学 神经学
- 皮肤病学 皮肤病学
- 流行病学 流行病学
背景情况:
- 的治疗通常涉及诸如林丹之类的杀剂,而林丹会带来神经毒性的风险.
- 长时间暴露在林丹中,特别是在农业中,已与神经退行性疾病有关,包括帕金森病 (PD).
研究的目的:
- 调查,林丹治疗和患帕金森病的风险之间的联系.
- 为了评估病患者,特别是那些接受局部林丹治疗的患者,是否有PD的发病率增加.
主要方法:
- 一项全国性基于人口的队列研究利用了台湾 (2000 - 2018) 的索赔数据.
- 包括27,173名病患者与对照组匹配,随访长达18年.
- 主要结局:新诊断的PD发生率;针对PD计算的危险比率 (HR),重点是用林丹治疗的患者.
主要成果:
- 与对照组相比,病患者的PD风险增加了1.46倍 (aHR1.46;95% CI 1.32-1.63).
- 相反,接受局部林丹治疗的患者患PD的风险显著降低 (aHR 0.15;95% CI 0.12-0.19).
- 在林丹治疗组中观察到较低的PD累积发病率.
结论:
- 与患帕金森病的风险增加有关.
- 林丹治疗显著降低了PD的风险,这表明潜在的神经保护性质.
相关概念视频
Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
483
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
483
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


